CONGRESS 2011

Program & Downloads

Click here to download the entire book (680KB) –
To navigate in the pages, please use the search tool or the bookmarks.

 

Click here to see the speakers list

Hepatitis C - Monday, January 17th 2011

  • 8:55 Optimal use of virological tools - Stefan ZEUZEM (Germany)
  • 9:15 Genetic markers: a major step for individualised care - John MCHUTCHISON (USA)
  • 9:35 Impact of SVR on the long term outcome of the liver disease - Alfredo ALBERTI (Italy)
  • 9:55 Serum markers or Fibroscan vs liver biopsy? - Laurent CASTERA (France)
  • 10:15 Round table - All speakers
  • 10:30 - 11:00 Coffee break
  • 11:00 The role of triple therapy in genotype 1:
  • 11:30 Optimal therapy in non-1 genotypes:
  • 12:00 Round table - All speakers
  • Are interferons really necessary? - Edward GANE (New Zealand))
  • 14:45 Round table - All speakers
  • 15:15 Clinical case: management of a non responder - Eugene SCHIFF (USA)
  • 15:45 – 16:15 Coffee break
  • 17:00 How I manage my patients with hepatocellular carcinoma - Massimo COLOMBO (Italy)
  • 17:15 The Zurich HCC liver transplantation consensus conference - Pierre-A. CLAVIEN (Switzerland)
  • 17:30 Round table - All speakers
  • 20:00 Congress dinner

Hepatitis B - Tuesday, January 18th 2011

  • 8:30 Impact of therapy on the long term outcome of liver disease - Yun-Fan LIAW (Taiwan)
  • 9:15 HBsAg: clinical relevance - Rami MOUCARI (United Arab Emirates)
  • 9:30 Round table - All speakers
  • 10:00 - 10:30 Coffee Break
  • 10:30 – 11:30 HBeAg-positive chronic hepatitis B - Chairpersons: Sam LEE (Canada) Ji Dong JIA (China)
  • 10:30 Why do I treat my patient with a nucleos(t)ide analogue? - Nancy LEUNG (Hong Kong)
  • 10:50 Why do I treat my patient with pegylated interferon? - Harry JANSSEN (The Netherlands)
  • 11:10 Round table - All speakers
  • 11:50 Why do I treat my patient with pegylated interferon? - Pietro LAMPERTICO (Italy)
  • 12:10 Round table - All speakers
  • 14:00 – 14:30 Clinical case: cirrhosis with lamivudine resistance - Marion PETERS (USA)
  • 14:30 HIV co-infection: does it make a difference? - Stanislas POL (France)
  • 14:50 Difficulties faced in severe reactivation - Didier SAMUEL (France)
  • 15:30 - 16:00 State of the Art lecture - Chairman: Tarik ASSELAH (France)